ArticleIranian journal of pharmaceutical research : IJPR
Dual TYK2/JAK1 Inhibition by Brepocitinib Reprograms Synoviocyte Pathobiology: Mechanistic Insights Into Targeted Therapy for Rheumatoid Arthritis.
Umar Saeed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.